Reg IV is a serum biomarker for gastric cancer patients and predicts response to 5-fluorouracil-based chemotherapy (Q40180989)
Jump to navigation
Jump to search
scientific article published on 22 January 2007
Language | Label | Description | Also known as |
---|---|---|---|
English | Reg IV is a serum biomarker for gastric cancer patients and predicts response to 5-fluorouracil-based chemotherapy |
scientific article published on 22 January 2007 |
Statements
1 reference
Reg IV is a serum biomarker for gastric cancer patients and predicts response to 5-fluorouracil-based chemotherapy (English)
1 reference
Mitani Y
1 reference
Oue N
1 reference
Matsumura S
1 reference
Yoshida K
1 reference
Noguchi T
1 reference
Ito M
1 reference
Tanaka S
1 reference
Kuniyasu H
1 reference
Kamata N
1 reference
Yasui W
1 reference
22 January 2007
1 reference
4383-4393
1 reference
1 reference
1 reference
Identifiers
1 reference